{Reference Type}: Case Reports
{Title}: A case of disappearing amyloid on technetium pyrophosphate scan.
{Author}: Wang A;Mahmood U;Tang X;Jain D;Pan S;
{Journal}: J Nucl Cardiol
{Volume}: 30
{Issue}: 5
{Year}: 2023 Oct
{Factor}: 3.872
{DOI}: 10.1007/s12350-023-03316-1
{Abstract}: Technetium-99mm pyrophosphate (Tc-PYP) scintigraphy is a highly accurate non-invasive method for the diagnosis of transthyretin (ATTR) cardiac amyloidosis. Prognosis for this disease is improved following treatment with the transthyretin (TTR) stabilizer tafamidis. Although tafamidis slows disease progression, its effects on myocardial amyloid and Tc-PYP uptake remain unclear. We present a patient with ATTR cardiac amyloidosis who had a strongly positive initial Tc-PYP scan, with a dramatic decrease in Tc-PYP uptake on repeat scan after 3 years of tafamidis treatment. However, myocardial biopsy showed persistent diffuse amyloid deposits. This case highlights the need for further studies regarding the utility of serial Tc-PYP scans in monitoring the progress of ATTR cardiomyopathy.